🎩
Investors
The Financiers
Traditional venture capital bets everything on one company, one team, one outcome. Emergent offers something different: a portfolio approach to software products, modeled on how film studios finance slates of movies.
Slate I is our inaugural collection of products — a diversified portfolio where hits cover experiments, and the studio retains the IP that endures.
The Thesis
- Portfolio Diversification — Multiple products, multiple markets, multiple shots on goal
- Lower Risk Per Bet — Smaller checks across more products vs. one big swing
- IP Retention — The studio owns the franchises; value compounds over time
- Operational Leverage — Shared infrastructure, learnings, and talent across productions
- Darwin Framework — Products evolve based on market feedback, not founder stubbornness
Slate I Details
- Target — 10 products across B2B SaaS, consumer, and AI-native categories
- Funding Model — Details shared with qualified investors
- Timeline — 18-24 month production cycle for the slate
- Returns — Revenue share from successful products, plus potential exits
What We're Looking For
- Aligned Investors — You get the thesis and have patience for portfolio returns
- Value-Add Welcome — Operational expertise, distribution, or domain knowledge
- Accredited Investors — This is a private offering
What to Include in Your Inquiry
- Who You Are — Brief background (individual, family office, fund, etc.)
- Investment Capacity — Range you're considering
- What Interests You — Why this model? What sectors excite you?
- Value-Add — Beyond capital, what do you bring?
All investor communications are handled with discretion. We'll follow up with a detailed deck and next steps.
← Back to Studio